go back

Bamlanivimab and Etesevimab Infusion, Home or Residence

Texas rates for HCPCS M0246

Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the COVID-19 public health emergency

Rates data updated July 2026.

How much rates vary

Facilitymedian $4,677 · 10th to 90th $4,677 to $4,677
$2K$5Kfacility $4,677

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Lucent Health
Setting
Facility
Modifier
Global
Typical Low
$4,677.35
Median
$4,677.35
Typical High
$4,677.35
United
Setting
Facility
Modifier
Global
Typical Low
$1,258.93
Median
$1,258.93
Typical High
$1,258.93